Zoic Capital partners with visionary founders at the intersection of hard science and impactful solutions, focusing on frontier technologies backed by robust intellectual property. Founded in 2014 to address the systematic underfunding of early-stage health technology startups, the firm invests from Seed to Series A, focusing on the first three rounds of capital to propel frontier science into commercial success. The firm’s foundational investment thesis is that “10X returns are reliably generated only by 10X improvements on the status quo.”